These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 8242621

  • 1. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F, Berger MS, Rajagopal S, Spence A, Livingston RB.
    Cancer Res; 1993 Dec 01; 53(23):5663-8. PubMed ID: 8242621
    [Abstract] [Full Text] [Related]

  • 2. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells.
    Ali-Osman F, Rairkar A, Young P.
    Cancer Biochem Biophys; 1995 Jan 01; 14(4):231-41. PubMed ID: 7767897
    [Abstract] [Full Text] [Related]

  • 3. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
    Hunter KJ, Deen DF, Pellarin M, Marton LJ.
    Cancer Res; 1990 May 01; 50(9):2769-72. PubMed ID: 2109657
    [Abstract] [Full Text] [Related]

  • 4. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
    Seidenfeld J, Barnes D, Block AL, Erickson LC.
    Cancer Res; 1987 Sep 01; 47(17):4538-43. PubMed ID: 3113720
    [Abstract] [Full Text] [Related]

  • 5. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ, Barnes DM, Fisher SG, Albain KS, Fisher RI, Erickson LC.
    Cancer Res; 1989 Mar 15; 49(6):1383-9. PubMed ID: 2924295
    [Abstract] [Full Text] [Related]

  • 6. DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.
    Ali-Osman F, Srivenugopal K, Berger MS, Stein DE.
    Anticancer Res; 1990 Mar 15; 10(3):677-82. PubMed ID: 2164350
    [Abstract] [Full Text] [Related]

  • 7. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
    Aida T, Bodell WJ.
    Cancer Res; 1987 Mar 01; 47(5):1361-6. PubMed ID: 3469016
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D, Jenkins WT, Meyn RE.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).
    Plooy AC, van Dijk M, Berends F, Lohman PH.
    Cancer Res; 1985 Sep 01; 45(9):4178-84. PubMed ID: 3928152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. DNA cross-linking and cytotoxicity induced by cis-diamminedichloroplatinum(II) in human normal and tumor cell lines.
    Laurent G, Erickson LC, Sharkey NA, Kohn KW.
    Cancer Res; 1981 Sep 01; 41(9 Pt 1):3347-51. PubMed ID: 7196283
    [Abstract] [Full Text] [Related]

  • 13. Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1992 May 15; 52(10):2782-90. PubMed ID: 1316227
    [Abstract] [Full Text] [Related]

  • 14. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
    Plooy AC, van Dijk M, Lohman PH.
    Cancer Res; 1984 May 15; 44(5):2043-51. PubMed ID: 6538808
    [Abstract] [Full Text] [Related]

  • 15. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA.
    Biochem Biophys Res Commun; 1999 Apr 13; 257(2):361-8. PubMed ID: 10198218
    [Abstract] [Full Text] [Related]

  • 16. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.
    Chatterjee S, Hirota H, Belfi CA, Berger SJ, Berger NA.
    Cancer Res; 1997 Nov 15; 57(22):5112-6. PubMed ID: 9371511
    [Abstract] [Full Text] [Related]

  • 17. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
    Fram RJ, Woda BA, Wilson JM, Robichaud N.
    Cancer Res; 1990 Jan 01; 50(1):72-7. PubMed ID: 2293559
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
    Swinnen LJ, Ellis NK, Erickson LC.
    Cancer Res; 1991 Apr 15; 51(8):1984-9. PubMed ID: 2009517
    [Abstract] [Full Text] [Related]

  • 19. Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1990 Oct 15; 50(20):6723-30. PubMed ID: 2170008
    [Abstract] [Full Text] [Related]

  • 20. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY, Li L, Keating MJ, Plunkett W.
    Mol Pharmacol; 1995 May 15; 47(5):1072-9. PubMed ID: 7746274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.